Evidence map›Paper›PMID 42163643›Full record

ArticleJournal of cell science2026

Progerin cross-linking stiffens the nucleus and impairs mechanosensation in Hutchinson-Gilford progeria syndrome.

Luv Kishore Srivastava, Ajinkya Ghagre, Ioannidis Duchastel-Vassaramva, Allen J Ehrlicher

Abstract read
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luv Kishore SrivastavaDepartment of Bioengineering, McGill University, Montreal H3A 0E9, Canada.
Ajinkya GhagreDepartment of Bioengineering, McGill University, Montreal H3A 0E9, Canada.
Ioannidis Duchastel-VassaramvaDepartment of Bioengineering, McGill University, Montreal H3A 0E9, Canada.
Allen J EhrlicherDepartment of Bioengineering, McGill University, Montreal H3A 0E9, Canada.ORCID 0000-0003-3030-979X

Funding

CIHR 185684CIHR 197896McGill University
6 · The paper itself

Abstract

Nuclear mechanosensation enables cells to detect and respond to mechanical cues through deformation governed by lamina and chromatin stiffness. In Hutchinson-Gilford progeria syndrome (HGPS), whether nuclear stiffening arises from progerin (a farnesylated variant form of lamin A) abundance alone and how it impacts mechanotransduction, remain unknown. Here, we show that progerin-driven cross-linking is the primary mechanical determinant of nuclear stiffness, and that this excessive stiffening impairs mechanosensation. We introduce a parameter called the cross-linked lamin expression factor (CLEF), which combines lamin abundance and immobile fraction as orthogonal components, and robustly predicts nuclear stiffness (r=0.84). Progerin aggregates tethered to the nuclear envelope induce persistent wrinkling resistant to hypotonic deformation, indicating stable mechanical anchoring. Strain mapping reveals that progerin spatial heterogeneity is a stronger local stiffness determinant than lamin A/C, and chromatin decompaction in HGPS makes progerin-rich lamina regions the dominant mechanical contributors. Excessive lamina cross-linking impairs YAP (also known as YAP1) nuclear translocation across multiple independent perturbations of lamina mechanics, disrupting mechanosensation. These findings provide a mechanistic framework connecting nuclear architecture to defective mechanotransduction in laminopathies.

Indexed as

Cell NucleusLamin Type AMechanotransduction, CellularProgeriaProtein PrecursorsChromatinHumansYAP-Signaling ProteinsChromatinLamin Type Aprelamin AProtein PrecursorsYAP-Signaling ProteinsChromatinHutchinson–Gilford progeria syndromeLamin A/CMechanotransductionNuclear mechanicsNuclear wrinklingProgerinYAP

Identifiers

PMID42163643
PMCPMC13327536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.